Yesterday (June 3, 2007) there was a report in Barron's which said several cardiologists and nephrologists raised questions about the safety TriCor. The drug helps lower triglycerides.
The doctors raised concerns that fenofibrate (TriCor) may cause decline in kidney functions.
Sources include Reuters and Barron's online. You'll need to login to read the rest.
